Supernus Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of SUPN for the last quarter is 164.31 M USD, and it's 6.78% higher compared to the previous quarter. The net income of Q4 23 is 1.18 M USD.